YaSheng Pharma: A revenue of 234 million yuan in the first half of the year, a decrease of 71.6% year-on-year.

Yasheng Pharmaceuticals announced on the Hong Kong Stock Exchange that as of June 30, 2025, the revenue for the six months ending on that date was 234 million yuan, a decrease of 71.6% year-on-year, mainly due to a decrease in intellectual property income generated during the six months ending on June 30, 2024. The net loss was 591 million yuan, compared to a profit of 163 million yuan in the same period last year, mainly due to the decrease in intellectual property income mentioned above.